Found 5 matching trials
Ropinirole 0.25 mg Tablets Under Fasting Conditions PHASE1 The objective of this study was to compare the relative bioavailability of ...
Show More Location
Novum Pharmaceutical Research Services
Learn More & Join Trial
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Und Fasted Conditions NA The objective of this study was to assess the single dose bioequivalence of...
Show More Location
Multiple Locations
Learn More & Join Trial
A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Under Fed Conditions NA The objective of this study was to assess the single dose bioequivalence of...
Show More Location
Multiple Locations
Learn More & Join Trial
Clinical Evaluation of Ropinirole IR (Immediate Release) Tablets in Patients Who Are Diagnosed With Symptomatic Restless Legs Syndrome (RLS) Associated With Chronic Kidney Disease (CKD) Managed With Haemodialysis (Including Haemofiltration and Haemodiafiltration) PHASE2 This is a multicenter, placebo controlled, parallel group, double-blind, ra...
Show More Location
GSK Investigational Site
Learn More & Join Trial
The Relative Bioavailability Study of Two Ropinirole 0.25 mg Tablets Under Fed Conditions PHASE1 The purpose of this study is to compare relative bioavailability of the tes...
Show More Location
Novum Pharmaceutical Research Services
Learn More & Join Trial